Loading resource…

UK Kidney Association
The document outlines clinical practice guidelines developed by the UK Kidney Association regarding anticoagulation therapy for patients with atrial fibrillation who also have advanced kidney disease. It discusses the pharmacokinetics of direct oral anticoagulants (DOACs) in patients with chronic kidney disease (CKD) and provides evidence-based recommendations for managing these patients to prevent thromboembolic events while minimizing bleeding risks. The guideline emphasizes the importance of individualized treatment plans based on renal function and other clinical factors.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology

Integrated CKD Management Guidelines for Uganda
Same clinical topic · Nephrology

KDIGO 2026 CLINICAL PRACTICE GUIDELINE FOR DIABETES AND CHAPTER 1, CHAPTER 2, & CHAPTER 4 UPDATE DRAFT
Same clinical topic · Nephrology

KDIGO 2025 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology

KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology

KDIGO-2024-CKD-Guideline
Same clinical topic · Nephrology

DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE: SYNOPSIS OF THE KDIGO 2022 CLINICAL PRACTICE GUIDELINE UPDATE
Same clinical topic · Nephrology

KDIGO 2023 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF LUPUS NEPHRITIS
Same clinical topic · Nephrology

KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease
Same clinical topic · Nephrology